160 related articles for article (PubMed ID: 24009708)
1. CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status.
Zeilstra J; Joosten SP; Vermeulen L; Koster J; Medema JP; Versteeg R; Spaargaren M; Pals ST
PLoS One; 2013; 8(8):e72849. PubMed ID: 24009708
[TBL] [Abstract][Full Text] [Related]
2. p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
Mulder JW; Wielenga VJ; Pals ST; Offerhaus GJ
Histochem J; 1997 Jun; 29(6):439-52. PubMed ID: 9248852
[TBL] [Abstract][Full Text] [Related]
3. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
[TBL] [Abstract][Full Text] [Related]
5. Epithelial X-Box Binding Protein 1 Coordinates Tumor Protein p53-Driven DNA Damage Responses and Suppression of Intestinal Carcinogenesis.
Welz L; Kakavand N; Hang X; Laue G; Ito G; Silva MG; Plattner C; Mishra N; Tengen F; Ogris C; Jesinghaus M; Wottawa F; Arnold P; Kaikkonen L; Stengel S; Tran F; Das S; Kaser A; Trajanoski Z; Blumberg R; Roecken C; Saur D; Tschurtschenthaler M; Schreiber S; Rosenstiel P; Aden K
Gastroenterology; 2022 Jan; 162(1):223-237.e11. PubMed ID: 34599932
[TBL] [Abstract][Full Text] [Related]
6. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
8. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance.
Joosten SPJ; Spaargaren M; Clevers H; Pals ST
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188437. PubMed ID: 32976979
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.
Godar S; Ince TA; Bell GW; Feldser D; Donaher JL; Bergh J; Liu A; Miu K; Watnick RS; Reinhardt F; McAllister SS; Jacks T; Weinberg RA
Cell; 2008 Jul; 134(1):62-73. PubMed ID: 18614011
[TBL] [Abstract][Full Text] [Related]
11. AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
Casado J; Iñigo-Chaves A; Jiménez-Ruiz SM; Ríos-Arrabal S; Carazo-Gallego Á; González-Puga C; Núñez MI; Ruíz-Extremera Á; Salmerón J; León J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604612
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
Solomon H; Dinowitz N; Pateras IS; Cooks T; Shetzer Y; Molchadsky A; Charni M; Rabani S; Koifman G; Tarcic O; Porat Z; Kogan-Sakin I; Goldfinger N; Oren M; Harris CC; Gorgoulis VG; Rotter V
Oncogene; 2018 Mar; 37(12):1669-1684. PubMed ID: 29343849
[TBL] [Abstract][Full Text] [Related]
14. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.
Cressey R; Pimpa S; Tontrong W; Watananupong O; Leartprasertsuke N
Cancer Lett; 2006 Feb; 233(2):232-9. PubMed ID: 15921850
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-cCSC1 promotes cell proliferation of colorectal cancer through sponging miR-124-3p and upregulating CD44.
Zhang HR; Wu SY; Fu ZX
Biochem Biophys Res Commun; 2021 Jun; 557():228-235. PubMed ID: 33887588
[TBL] [Abstract][Full Text] [Related]
17. Multiple intron retention occurs in tumor cell CD44 mRNA processing.
Goodison S; Yoshida K; Churchman M; Tarin D
Am J Pathol; 1998 Oct; 153(4):1221-8. PubMed ID: 9777953
[TBL] [Abstract][Full Text] [Related]
18. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
19. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
20. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]